Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis

NCT07580716 is registered in ClinicalTrials.gov with Enlivex Therapeutics Ltd. as lead sponsor.

NCT NCT07580716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07580716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis
Lead sponsor
Enlivex Therapeutics Ltd.
Phase
Phase 2
Overall status
Recruiting
Start date
May 1, 2026
Completion date
April 30, 2028
Enrollment
182 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

primary knee osteoarthritis